Testing effectiveness (Phase 2)Ended earlyNCT03790111
What this trial is testing
A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract Cancer
Who this might be right for
Biliary Tract Cancer (BTC)
TerSera Therapeutics LLC 53